Industry update Jazz Pharma to buy CBD drugmaker GW Pharma for US$7.2B Shares of GW skyrocketed nearly 50% after the companies revealed the largest acquisition in the cannabis sector to date Jared GnamFebruary 4, 2021
CBD Martha Stewart and Canopy Growth release CBD dog treats — but are they safe? While initial research suggests CBD is well-tolerated in pups, even Canopy recommends consulting your vet before starting any cannabis treatment Ashley KeenanJanuary 31, 2021
Canada Ontario set to be first province to launch farmgate sales this year Producers say on-site stores will increase product quality, consumer education and revenues, while creating jobs and tourism opportunities Jared GnamJanuary 29, 2021
Industry update Aphria stock hits 2-year high on record Q2 sales The firm's valuation is rocketing along with most pot stocks, but uncertainty remains if it can better capitalize on both domestic and international markets Nick LabaJanuary 14, 2021
Industry update Hexo, Molson Coors launch first US CBD drinks in Colorado Beer giant and Quebec pot producer plan to expand CBD beverage line as American regulatory framework develops Jared GnamJanuary 13, 2021
Industry update US FDA unveils plan to gather ‘real-world’ data to fill CBD research gaps After two years of delaying regulations, the agency looks to improve data-gathering methods on CBD product safety Jared GnamJanuary 11, 2021
Extraction Canopy’s GW Pharma lawsuit could be trouble for US extractors Canopy has a fair shot at winning its suit against GW, but the case might not have a widespread effect on US pot extractors,... Jared GnamDecember 24, 2020
Industry update Canopy Growth inks $297M deal to give up stake in Canopy Rivers The Canadian weed giant is cutting ties with its venture capital firm that will have the freedom to focus on the U.S. market Jared GnamDecember 21, 2020
Industry update Canopy shutters 5 Canadian facilities, beverage boss walks Canadian weed giant to lay off 220 workers in an effort to save up to $200M Jared GnamDecember 9, 2020
Analysis Ontario speeds up cannabis retail approvals again amid applicant frustration But approving 80 retail licences a month will lead to saturation in some regions, according to BCMI analyst Chris Damas Jared GnamDecember 9, 2020